Adopting AI for R&D in 2025 – what needs to be addressed?
European Pharmaceutical Review
DECEMBER 19, 2024
Yet, AI remains the top area for investment over the next two years, according to 62 percent of respondents in Pistoias 2024 Lab of the Future report. For example, our 2024 paper on good machine learning practices, 7 or our FAIR Toolkit. Partly this perception is driven by challenges around the quality of content used to train AI.
Let's personalize your content